235 related articles for article (PubMed ID: 10895181)
1. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
Shimizu Y
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
[TBL] [Abstract][Full Text] [Related]
3. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy for advanced cervical cancer].
Kodama J; Ikuhashi H; Hongo A; Mizutani Y; Miyagi Y; Yoshinouchi M; Kobashi Y; Okuda H; Kudo T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):89-92. PubMed ID: 9987503
[TBL] [Abstract][Full Text] [Related]
6. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP].
Matsui R; Kashihara K; Higashi T; Seo K; Taoka Y; Yoshida S; Nishitani H; Takegawa Y; Hukumura Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1985-8. PubMed ID: 8978808
[TBL] [Abstract][Full Text] [Related]
10. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
Moore KN; Herzog TJ; Lewin S; Giuntoli RL; Armstrong DK; Rocconi RP; Spannuth WA; Gold MA
Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy with intra-arterial infusion in the treatment of advanced cervical cancer].
Mizuno K; Kidokoro K; Miyazaki K; Yoshida K; Nakagawa A; Mizuno M; Suzuki S; Kuno N; Furuhashi M; Ishizuka T; Ishikawa K
Gan To Kagaku Ryoho; 2005 Jun; 32(6):815-9. PubMed ID: 15984522
[TBL] [Abstract][Full Text] [Related]
12. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
Kastritis E; Bamias A; Efstathiou E; Gika D; Bozas G; Zorzou P; Sarris K; Papadimitriou C; Dimopoulos MA
Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
Yamakawa Y; Fujimura M; Hidaka T; Hori S; Saito S
Gynecol Oncol; 2000 May; 77(2):264-70. PubMed ID: 10785476
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin-adriamycin-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent cervical carcinoma.
Sorbe B; Frankendal B
Obstet Gynecol; 1984 Feb; 63(2):167-70. PubMed ID: 6198610
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Iwasaka T; Fukuda K; Hara K; Yokoyama M; Nakao Y; Uchiyama M; Sugimori H
Gynecol Oncol; 1998 Aug; 70(2):236-40. PubMed ID: 9740697
[TBL] [Abstract][Full Text] [Related]
17. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
[TBL] [Abstract][Full Text] [Related]
18. Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Umesaki N; Izumi R; Fushiki H; Hasegawa K; Kono I; Nishida M; Noguchi H; Okuda H; Sugimori H; Takizawa K; Udagawa Y; Yamamoto K; Tanaka T; Noda K
Gynecol Oncol; 1999 Oct; 75(1):142-4. PubMed ID: 10502441
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
[TBL] [Abstract][Full Text] [Related]
20. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]